TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 33)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
FIGURE 1 EMPTY CAPSULES MARKET SEGMENTATION
1.3.1 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY (Page No. - 37)
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.2 PRIMARY RESEARCH
FIGURE 3 EMPTY CAPSULES MARKET SIZE: PRIMARY RESPONDENTS
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 4 MARKET SIZE ESTIMATION, BY VALUE (2022)
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
FIGURE 6 MARKET VOLUME ESTIMATION, 2022
2.2.1 INSIGHTS FROM PRIMARY EXPERTS
FIGURE 7 INSIGHTS ON MARKET FROM PRIMARY EXPERTS
2.3 EMPTY PILLS MARKET: GROWTH RATE PROJECTIONS
FIGURE 8 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS (DEMAND SIDE): GROWTH OF DEMAND-SIDE FACTORS
2.4 DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS OF RISK
3 EXECUTIVE SUMMARY (Page No. - 46)
FIGURE 10 EMPTY CAPSULES MARKET SIZE, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 11 FILLABLE CAPSULES MARKET, BY FUNCTIONALITY, 2023 VS. 2028 (USD MILLION)
FIGURE 12 EMPTY PILLS MARKET, BY THERAPEUTIC APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 13 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF MARKET
4 PREMIUM INSIGHTS (Page No. - 50)
4.1 EMPTY CAPSULES MARKET OVERVIEW
FIGURE 15 INCREASING DEMAND FOR NUTRACEUTICALS TO DRIVE GROWTH
4.2 NORTH AMERICA: EMPTY PILLS MARKET, BY TYPE AND COUNTRY (2022)
FIGURE 16 GELATIN CAPSULES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.3 MARKET SHARE, BY APPLICATION, 2023 VS. 2028
FIGURE 17 ANTIBIOTIC AND ANTIBACTERIAL DRUGS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.4 FILLABLE CAPSULES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 52)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 EMPTY CAPSULES MARKET SIZE: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 1 EMPTY PILLS MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing demand for nutraceuticals
5.2.1.2 Growth in pharmaceutical market and increasing number of clinical trials and R&D activities
5.2.1.3 Advancements in capsule delivery technologies
5.2.1.4 Benefits of capsules over other dosage forms
5.2.2 RESTRAINTS
5.2.2.1 Cultural practices and dietary restrictions
5.2.3 OPPORTUNITIES
5.2.3.1 Expansion of capsule production in emerging countries
5.2.3.2 Development of halal gelatin and vegetarian capsules
5.2.4 CHALLENGES
5.2.4.1 Rising prices and lower availability of raw materials in gelatin industry
5.3 EMPTY CAPSULE MARKET TRENDS / DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 20 REVENUE SHIFT AND NEW REVENUE POCKETS
5.4 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS OF PRICING
TABLE 2 AVERAGE PRICE OF EMPTY CAPSULES, BY REGION (2022)
5.5 TECHNOLOGY ANALYSIS
5.5.1 ENTERIC CAPSULE TECHNOLOGIES
5.5.2 PROTEIN DELIVERY CAPSULE TECHNOLOGIES
5.6 VALUE CHAIN ANALYSIS
FIGURE 21 FILLABLE CAPSULES MARKET: VALUE CHAIN ANALYSIS
5.7 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS OF ECOSYSTEM
FIGURE 22 ECOSYSTEM ANALYSIS: MARKET
TABLE 3 ROLE IN ECOSYSTEM
5.8 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 MARKET: PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 BARGAINING POWER OF BUYERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY
5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF EMPTY CAPSULES
FIGURE 24 KEY BUYING CRITERIA FOR EMPTY CAPSULES
5.10 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS OF PATENT
FIGURE 25 PATENT APPLICATIONS RELATED TO EMPTY CAPSULES, JANUARY 2012–MARCH 2023
TABLE 5 LIST OF FEW PATENTS IN MARKET
5.11 TRADE ANALYSIS
TABLE 6 EXPORT DATA FOR HS CODE 960200 (TOP 10 COUNTRIES)
TABLE 7 IMPORT DATA FOR HS CODE 960200 (TOP 10 COUNTRIES)
5.12 REGULATORY ANALYSIS
5.13 PHARMACEUTICAL GELATIN MARKET
5.14 EMPTY CAPSULE MARKET TRENDS
5.14.1 RISING DEMAND FOR EMPTY CAPSULES IN NUTRACEUTICAL AND COSMETICS INDUSTRIES
5.14.2 GROWING DEMAND AND ADOPTION OF VEGETARIAN/NON-GELATIN CAPSULES
6 GLOBAL EMPTY CAPSULES MARKET SIZE, BY TYPE (Page No. - 72)
6.1 INTRODUCTION
TABLE 8 EMPTY PILLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 9 FILLABLE CAPSULES MARKET, BY TYPE, 2021–2028 (BILLION UNITS)
6.2 GELATIN CAPSULES
TABLE 10 GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 11 GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 12 GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (BILLION UNITS)
TABLE 13 NORTH AMERICA: GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 14 EUROPE: GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 15 ASIA PACIFIC: GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.1 PORCINE GELATIN
6.2.1.1 Porcine gelatin segment to dominate market
TABLE 16 PORCINE GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 17 NORTH AMERICA: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 18 EUROPE: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 19 ASIA PACIFIC: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2 BOVINE-DERIVED GELATIN
6.2.2.1 Bovine-derived gelatin widely accepted in halal pharmaceuticals market
TABLE 20 BOVINE-DERIVED GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 21 NORTH AMERICA: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 22 EUROPE: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 23 ASIA PACIFIC: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.3 BONE MEAL
6.2.3.1 Bone meal gelatin gained importance in recent years
TABLE 24 BONE MEAL GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 25 NORTH AMERICA: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 EUROPE: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 27 ASIA PACIFIC: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.4 OTHER GELATIN SOURCES
TABLE 28 OTHER GELATIN SOURCE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 29 NORTH AMERICA: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 30 EUROPE: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 31 ASIA PACIFIC: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 NON-GELATIN CAPSULES
TABLE 32 NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 33 NON-GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 34 NON-GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (BILLION UNITS)
TABLE 35 NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 EUROPE: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1 HYDROXYPROPYL METHYLCELLULOSE
6.3.1.1 HPMC dominates non-gelatin capsules market
TABLE 38 HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 39 NORTH AMERICA: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 40 EUROPE: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 41 ASIA PACIFIC: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2 PULLULAN AND STARCH
6.3.2.1 High manufacturing costs offset advantageous aspects of pullulan and starch
TABLE 42 PULLULAN AND STARCH CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 43 NORTH AMERICA: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 EUROPE: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 45 ASIA PACIFIC: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 GLOBAL EMPTY CAPSULES MARKET SIZE, BY FUNCTIONALITY (Page No. - 92)
7.1 INTRODUCTION
TABLE 46 EMPTY PILLS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
7.2 IMMEDIATE-RELEASE CAPSULES
7.2.1 INCREASING APPLICATIONS OF IMMEDIATE-RELEASE CAPSULES TO PROPEL MARKET
TABLE 47 IMMEDIATE-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 48 NORTH AMERICA: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 EUROPE: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 50 ASIA PACIFIC: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 SUSTAINED-RELEASE CAPSULES
7.3.1 RISING USE OF SUSTAINED-RELEASE FORMULATIONS IN TREATING CHRONIC DISEASES TO DRIVE MARKET
TABLE 51 SUSTAINED-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 52 NORTH AMERICA: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 53 EUROPE: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 ASIA PACIFIC: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 DELAYED-RELEASE CAPSULES
7.4.1 GROWING PREFERENCE FOR TARGETED DRUG DELIVERY TO FUEL MARKET GROWTH
TABLE 55 DELAYED-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 56 NORTH AMERICA: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 57 EUROPE: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 ASIA PACIFIC: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
8 GLOBAL EMPTY CAPSULES MARKET SHARE, BY THERAPEUTIC APPLICATION (Page No. - 100)
8.1 INTRODUCTION
TABLE 59 EMPTY PILLS MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
8.2 ANTIBIOTIC AND ANTIBACTERIAL DRUGS
8.2.1 EMERGENCE OF NOVEL ANTIBIOTICS IN CAPSULE FORM AND INCREASING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
TABLE 60 MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY REGION, 2021–2028 (USD MILLION)
TABLE 61 NORTH AMERICA: MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 62 EUROPE: MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 63 ASIA PACIFIC: MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 DIETARY SUPPLEMENTS
8.3.1 RISING DEMAND FOR DIETARY SUPPLEMENTS TO SUPPORT GROWTH
TABLE 64 MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 65 NORTH AMERICA: MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 66 EUROPE: MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 67 ASIA PACIFIC: MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 ANTACID AND ANTIFLATULENT PREPARATIONS
8.4.1 INCREASING DEMAND FOR GASTROINTESTINAL FORMULATIONS TO DRIVE MARKET
TABLE 68 MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 69 NORTH AMERICA: MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 70 EUROPE: MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 71 ASIA PACIFIC: MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 ANTIANEMIC PREPARATIONS
8.5.1 RISING INCIDENCE OF ANEMIA WORLDWIDE TO DRIVE GROWTH
TABLE 72 EMPTY CAPSULES MARKET SHARE FOR ANTIANEMIC PREPARATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 73 NORTH AMERICA: MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 EUROPE: MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 75 ASIA PACIFIC: MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8.6 ANTI-INFLAMMATORY DRUGS
8.6.1 RISING EMPHASIS ON GENERICS TO FAVOR MARKET GROWTH
TABLE 76 FILLABLE CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY REGION, 2021–2028 (USD MILLION)
TABLE 77 NORTH AMERICA: MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 78 EUROPE: MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 ASIA PACIFIC: MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
8.7 CARDIOVASCULAR THERAPY DRUGS
8.7.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO CONTRIBUTE TO MARKET GROWTH
TABLE 80 MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY REGION, 2021–2028 (USD MILLION)
TABLE 81 NORTH AMERICA: MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 82 EUROPE: MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 83 ASIA PACIFIC: MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
8.8 COUGH AND COLD DRUGS
8.8.1 GROWING ADOPTION OF OTC FORMULATIONS AND SELF-MEDICATION PRACTICES TO DRIVE GROWTH
TABLE 84 MARKET FOR COUGH AND COLD DRUGS, BY REGION, 2021–2028 (USD MILLION)
TABLE 85 NORTH AMERICA: MARKET FOR COUGH AND COLD DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 86 EUROPE: MARKET FOR COUGH AND COLD DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 87 ASIA PACIFIC: MARKET FOR COUGH AND COLD DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
8.9 OTHER THERAPEUTIC APPLICATIONS
TABLE 88 MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 89 NORTH AMERICA: MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 90 EUROPE: MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 91 ASIA PACIFIC: MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
9 GLOBAL EMPTY CAPSULES MARKET SHARE, BY END USER (Page No. - 118)
9.1 INTRODUCTION
TABLE 92 EMPTY PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2 PHARMACEUTICAL INDUSTRY
9.2.1 INCREASING EMPHASIS ON DRUG DEVELOPMENT TO DRIVE GROWTH
TABLE 93 MARKET FOR PHARMACEUTICAL INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
TABLE 94 NORTH AMERICA: MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 95 EUROPE: MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 96 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 NUTRACEUTICAL INDUSTRY
9.3.1 INCREASING DEMAND FOR DIETARY SUPPLEMENTS IN DEVELOPED AND DEVELOPING COUNTRIES TO SUPPORT GROWTH
TABLE 97 MARKET FOR NUTRACEUTICAL INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
TABLE 98 NORTH AMERICA: MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 99 EUROPE: MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 100 ASIA PACIFIC: MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 COSMETICS INDUSTRY
9.4.1 GELATIN-BASED CAPSULES ARE IDEAL FOR DELIVERING COSMETIC PRODUCTS
TABLE 101 FILLABLE CAPSULES MARKET FOR COSMETICS INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
TABLE 102 NORTH AMERICA: MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 103 EUROPE: MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 104 ASIA PACIFIC: MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
9.5 RESEARCH LABORATORIES
9.5.1 RISING CLINICAL TRIAL ACTIVITY TO DRIVE MARKET GROWTH
TABLE 105 MARKET FOR RESEARCH LABORATORIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 106 NORTH AMERICA: MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 107 EUROPE: MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 108 ASIA PACIFIC: MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
10 GLOBAL EMPTY CAPSULES MARKET SHARE, BY REGION (Page No. - 128)
10.1 INTRODUCTION
TABLE 109 EMPTY PILLS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 110 MARKET, BY REGION, 2021–2028 (BILLION UNITS)
10.2 NORTH AMERICA
FIGURE 26 NORTH AMERICA: EMPTY CAPSULES MARKET SNAPSHOT
TABLE 111 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 112 NORTH AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 113 NORTH AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 114 NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 115 NORTH AMERICA: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 116 NORTH AMERICA: MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 117 NORTH AMERICA: FILLABLE CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.1 US
10.2.1.1 US to dominate North American market during forecast period
TABLE 118 US: EMPTY CAPSULES MARKET SHARE, BY TYPE, 2021–2028 (USD MILLION)
TABLE 119 US: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 120 US: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 121 US: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 122 US: MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 123 US: MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Rising government focus on utilization of generics as means for controlling healthcare expenditure to drive growth
TABLE 124 CANADA: EMPTY CAPSULES MARKET FORECAST, BY TYPE, 2021–2028 (USD MILLION)
TABLE 125 CANADA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 126 CANADA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 127 CANADA: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 128 CANADA: EMPTY CAPSULES MARKET PREDICTION, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 129 CANADA: EMPTY PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.3 NORTH AMERICA: RECESSION IMPACT
10.3 EUROPE
TABLE 130 EUROPE: EMPTY CAPSULES MARKET FORECAST, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 131 EUROPE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 132 EUROPE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 133 EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 134 EUROPE: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 135 EUROPE: EMPTY CAPSULES MARKET PREDICTION, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 136 EUROPE: FILLABLE CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Presence of large number of pharmaceutical and nutraceutical manufacturers propelling demand for empty capsules
TABLE 137 GERMANY: EMPTY CAPSULES MARKET FORECAST, BY TYPE, 2021–2028 (USD MILLION)
TABLE 138 GERMANY: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 139 GERMANY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 140 GERMANY: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 141 GERMANY: MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 142 GERMANY: EMPTY CAPSULES MARKET PREDICTION, BY END USER, 2021–2028 (USD MILLION)
10.3.2 UK
10.3.2.1 Rising adoption of generics to drive market growth
TABLE 143 UK: EMPTY CAPSULES MARKET FORECAST, BY TYPE, 2021–2028 (USD MILLION)
TABLE 144 UK: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 145 UK: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 146 UK: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 147 UK: EMPTY CAPSULES MARKET PREDICTION, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 148 UK: EMPTY PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 High demand for pharmaceutical products to drive market growth
TABLE 149 FRANCE: EMPTY CAPSULES MARKET FORECAST, BY TYPE, 2021–2028 (USD MILLION)
TABLE 150 FRANCE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 151 FRANCE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 152 FRANCE: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 153 FRANCE: EMPTY CAPSULES MARKET PREDICTION, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 154 FRANCE: FILLABLE CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Growing presence of small and medium-sized CMOs likely to drive market
TABLE 155 ITALY: EMPTY CAPSULES MARKET TRENDS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 156 ITALY: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 157 ITALY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 158 ITALY: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 159 ITALY: MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 160 ITALY: EMPTY CAPSULES MARKET SEGMENTATION, BY END USER, 2021–2028 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Consolidation of biotechnology sector and availability of government support to drive growth
TABLE 161 SPAIN: EMPTY CAPSULES MARKET TRENDS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 162 SPAIN: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 163 SPAIN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 164 SPAIN: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 165 SPAIN: EMPTY CAPSULES MARKET SEGMENTATION, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 166 SPAIN: EMPTY PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 167 REST OF EUROPE: EMPTY CAPSULES MARKET TRENDS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 168 REST OF EUROPE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 169 REST OF EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 170 REST OF EUROPE: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 171 REST OF EUROPE: EMPTY CAPSULES MARKET SEGMENTATION, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 172 REST OF EUROPE: FILLABLE CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.7 EUROPE: RECESSION IMPACT
10.4 ASIA PACIFIC
FIGURE 27 ASIA PACIFIC: EMPTY CAPSULES MARKET SNAPSHOT
TABLE 173 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 174 ASIA PACIFIC: MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 175 ASIA PACIFIC: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 176 ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 177 ASIA PACIFIC: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 178 ASIA PACIFIC: MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 179 ASIA PACIFIC: EMPTY CAPSULES MARKET SEGMENTATION, BY END USER, 2021–2028 (USD MILLION)
10.4.1 CHINA
10.4.1.1 Low manufacturing costs on account of availability of raw materials to accelerate growth
TABLE 180 CHINA: EMPTY CAPSULES MARKET TRENDS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 181 CHINA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 182 CHINA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 183 CHINA: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 184 CHINA: EMPTY CAPSULES MARKET SEGMENTATION, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 185 CHINA: EMPTY PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Japan to be largest market for empty capsules in Asia Pacific
TABLE 186 JAPAN: EMPTY CAPSULES MARKET TRENDS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 187 JAPAN: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 188 JAPAN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 189 JAPAN: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 190 JAPAN: EMPTY CAPSULES MARKET GROWTH, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 191 JAPAN: FILLABLE CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Increased exports of empty capsules to drive market growth
TABLE 192 INDIA: EMPTY CAPSULES MARKET OVERVIEW, BY TYPE, 2021–2028 (USD MILLION)
TABLE 193 INDIA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 194 INDIA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 195 INDIA: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 196 INDIA: MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 197 INDIA: EMPTY CAPSULES MARKET GROWTH, BY END USER, 2021–2028 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 198 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET OVERVIEW, BY TYPE, 2021–2028 (USD MILLION)
TABLE 199 REST OF ASIA PACIFIC: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 200 REST OF ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 201 REST OF ASIA PACIFIC: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 202 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET GROWTH, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 203 REST OF ASIA PACIFIC: EMPTY PILLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.5 ASIA PACIFIC: RECESSION IMPACT
10.5 LATIN AMERICA
10.5.1 STRATEGIC EXPANSIONS BY LEADING MARKET PLAYERS TO DRIVE GROWTH
TABLE 204 LATIN AMERICA: EMPTY CAPSULES MARKET OVERVIEW, BY TYPE, 2021–2028 (USD MILLION)
TABLE 205 LATIN AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 206 LATIN AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 207 LATIN AMERICA: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 208 LATIN AMERICA: EMPTY CAPSULES MARKET GROWTH, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 209 LATIN AMERICA: FILLABLE CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.2 LATIN AMERICA: RECESSION IMPACT
10.6 MIDDLE EAST & AFRICA
10.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET
TABLE 210 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET OVERVIEW, BY TYPE, 2021–2028 (USD MILLION)
TABLE 211 MIDDLE EAST & AFRICA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 212 MIDDLE EAST & AFRICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 213 MIDDLE EAST & AFRICA: MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
TABLE 214 MIDDLE EAST & AFRICA: MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
TABLE 215 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET GROWTH, BY END USER, 2021–2028 (USD MILLION)
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
11 COMPETITIVE LANDSCAPE (Page No. - 183)
11.1 INTRODUCTION
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
FIGURE 28 GLOBAL EMPTY CAPSULES MARKET OVERVIEW: STRATEGIES ADOPTED
11.3 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS FOR MARKET SHARE
FIGURE 29 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS OF MARKET SHARE, BY KEY PLAYER (2022)
TABLE 216 EMPTY PILLS MARKET: DEGREE OF COMPETITION
11.4 REVENUE ANALYSIS
FIGURE 30 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS OF REVENUE FOR KEY COMPANIES (2020–2022)
11.5 COMPANY EVALUATION MATRIX
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 31 FILLABLE CAPSULES MARKET: COMPANY EVALUATION MATRIX, 2022
11.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 32 MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
11.7 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
11.7.1 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
TABLE 217 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS OF OVERALL FOOTPRINT OF KEY PLAYERS
11.7.2 INDUSTRY FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 218 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS OF INDUSTRY FOOTPRINT OF KEY PLAYERS
11.7.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 219 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS OF REGIONAL FOOTPRINT OF KEY PLAYERS
11.7.4 OFFERING FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 220 TWO-PIECE EMPTY HARD CAPSULE MARKET ANALYSIS OF OFFERING FOOTPRINT OF KEY PLAYERS
11.8 COMPETITIVE BENCHMARKING OF START-UPS/SMES
TABLE 221 EMPTY PILLS MARKET: DETAILED LIST OF KEY START-UPS/SMES
TABLE 222 MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
11.9 COMPETITIVE SCENARIO AND EMPTY CAPSULE MARKET TRENDS
11.9.1 PRODUCT LAUNCHES
TABLE 223 FILLABLE CAPSULES MARKET: PRODUCT LAUNCHES, JANUARY 2020–MARCH 2023
11.9.2 DEALS
TABLE 224 MARKET: DEALS, JANUARY 2020–MARCH 2023
11.9.3 OTHER DEVELOPMENTS
TABLE 225 EMPTY PILLS MARKET: OTHER DEVELOPMENTS, JANUARY 2020–MARCH 2023
12 COMPANY PROFILES (Page No. - 198)
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
12.1 KEY PLAYERS
12.1.1 CAPSUGEL (LONZA GROUP LTD.)
TABLE 226 CAPSUGEL (LONZA GROUP): BUSINESS OVERVIEW
FIGURE 33 LONZA GROUP LTD.: COMPANY SNAPSHOT (2022)
12.1.2 ACG
TABLE 227 ACG: BUSINESS OVERVIEW
12.1.3 MITSUBISHI CHEMICAL HOLDINGS CORPORATION
TABLE 228 QUALICAPS (MITSUBISHI CHEMICAL HOLDINGS CORPORATION): BUSINESS OVERVIEW
FIGURE 34 QUALICAPS (MITSUBISHI CHEMICAL HOLDINGS CORPORATION): COMPANY SNAPSHOT (2021)
12.1.4 CAPSCANADA CORPORATION
TABLE 229 CAPSCANADA CORPORATION: BUSINESS OVERVIEW
12.1.5 NATURAL CAPSULES
TABLE 230 NATURAL CAPSULES: BUSINESS OVERVIEW
FIGURE 35 NATURAL CAPSULES: COMPANY SNAPSHOT (2021)
12.1.6 SUHEUNG
TABLE 231 SUHEUNG: BUSINESS OVERVIEW
12.1.7 NECTAR LIFESCIENCES LTD.
TABLE 232 NECTAR LIFESCIENCES LTD.: BUSINESS OVERVIEW
FIGURE 36 NECTAR LIFESCIENCES LTD.: COMPANY SNAPSHOT (2021)
12.1.8 QINGDAO YIQING MEDICINAL CAPSULE (BAOTOU DONGBAO BIOTECHNOLOGY CO., LTD.)
TABLE 233 QINGDAO YIQING MEDICINAL CAPSULE: BUSINESS OVERVIEW
12.1.9 SHANXI GUANGSHENG MEDICINAL CAPSULE
TABLE 234 SHANXI GUANGSHENG MEDICINAL CAPSULE: BUSINESS OVERVIEW
12.1.10 HEALTHCAPS INDIA
TABLE 235 HEALTHCAPS INDIA: BUSINESS OVERVIEW
12.1.11 MEDI-CAPS
TABLE 236 MEDI-CAPS: BUSINESS OVERVIEW
FIGURE 37 MEDI-CAPS: COMPANY SNAPSHOT (2021)
12.1.12 SNAIL PHARMA INDUSTRY
TABLE 237 SNAIL PHARMA INDUSTRY: BUSINESS OVERVIEW
12.1.13 ROXLOR
TABLE 238 ROXLOR: BUSINESS OVERVIEW
12.1.14 SUNIL HEALTHCARE
TABLE 239 SUNIL HEALTHCARE: BUSINESS OVERVIEW
FIGURE 38 SUNIL HEALTHCARE: COMPANY SNAPSHOT (2021)
12.1.15 BIOCAPS ENTERPRISE
TABLE 240 BIOCAPS ENTERPRISE: BUSINESS OVERVIEW
12.1.16 BRIGHT PHARMA CAPS
TABLE 241 BRIGHT PHARMA CAPS: BUSINESS OVERVIEW
12.2 OTHER COMPANIES
12.2.1 COMED CHEMICALS
TABLE 242 COMED CHEMICALS: BUSINESS OVERVIEW
12.2.2 SAVIOUR CAPS
TABLE 243 SAVIOUR CAPS: BUSINESS OVERVIEW
12.2.3 FORTCAPS HEALTHCARE
TABLE 244 FORTCAPS HEALTHCARE: BUSINESS OVERVIEW
12.2.4 SHAOXING ZHONGYA CAPSULE
TABLE 245 SHAOXING ZHONGYA CAPSULE: BUSINESS OVERVIEW
12.2.5 ERAWAT PHARMA LIMITED
TABLE 246 ERAWAT PHARMA LIMITED: BUSINESS OVERVIEW
12.2.6 FARMACAPSULAS
TABLE 247 FARMACAPSULAS: BUSINESS OVERVIEW
12.2.7 ZHEJIANG YUEXI CAPSULE
12.2.8 LFA MACHINES OXFORD
12.2.9 SHAOXING KANGKE CAPSULE
12.2.10 SHREE PHARMA CAPS
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 241)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
Growth opportunities and latent adjacency in Empty Capsules Market